Habico Invest
Energivej 15, Odense S, Syddanmark, 5260, Denmark
Overview
Habico Invest is a Single Family Office serving the Bøgh-Sørensen family. Habico invests across a broad range of asset classes including public, private and alternatives. Habico is for the most part sector and stage agnostic, that said a preference is placed on earlier stage ventures where a proof-of-concept and revenues have been established.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 3
Investment portfolio
- Allos
Participated · Seed · Jan 2026
Allos AI applies Causal AI to model how formulation, dosing, delivery, and patient biology interact, allowing pharmaceutical partners to redesign existing complex generics and next-generation small-molecule drugs for chronic diseases. Its platform leverages real-world evidence to reduce development uncertainty, shorten clinical timelines, and create more predictable paths to regulatory approval. By turning drug reformulation into a data-driven engineering discipline, Allos aims to revive long-stalled development pathways and unlock stalled programs. The company’s transparent, or “glass-box,” models enable smaller and more interpretable clinical studies that accommodate patient heterogeneity upfront. Funding will be used to expand formulation development and data-science teams while focusing on hard-to-genericize medicines. Allos collaborates with pharmaceutical companies to modernize legacy assets and expand access to complex generics. Headquartered in Oxford, United Kingdom, the AI-native company was founded by an Oxford-trained quantum physicist, applied AI researchers, and veterans of complex generics.